Nospharma logo
VerifiedBiotechnology Research· Founded 2022

Nospharma

Nospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.

7-day free trial · no credit card

HeadquartersMontreal, CanadaEmployees3(1 to 10)Founded year2022Websitenospharma.caLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

3

1 to 10 range

Open roles

no listings

Distinct roles

1

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Nospharma

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

No verified contacts on record for this company yet.

Top roles at Nospharma

1 distinct titles indexed · top 1 shown.

  • 1strategy analyst intern

Sign up to unlock all 1 contacts at Nospharma

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Nospharma

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Nospharma | Kipplo Discover